Pfizer market cap is $208.3 b, and annual revenue was $51.75 b in FY 2019

Pfizer Gross profit (Q1, 2020)9.7 B

Pfizer Gross profit margin (Q1, 2020), %80.2%

Pfizer Net income (Q1, 2020)3.4 B

Pfizer EBIT (Q1, 2020)3.4 B

Pfizer Cash, 29-Mar-20202.2 B

Pfizer EV258.4 B

Pfizer revenue was $51.75 b in FY, 2019

Pfizer revenue breakdown by business segment: 40.2% from Essential Health and 59.8% from Innovative Health

Pfizer revenue breakdown by geographic segment: 49.5% from United States, 16.2% from Developed Europe, 12.6% from Developed Rest of World and 21.7% from Emerging Markets

USD | FY, 2015 | FY, 2016 | FY, 2017 | FY, 2018 | FY, 2019 |
---|---|---|---|---|---|

## Revenue | 48.9b | 52.8b | 52.5b | 53.6b | 51.8b |

| (2%) | 8% | (1%) | ||

## Cost of goods sold | 9.6b | 12.3b | 11.2b | 11.2b | 10.2b |

## Gross profit | 39.2b | 40.5b | 41.3b | 42.4b | 41.5b |

| 80% | 77% | 79% | 79% | 80% |

## Sales and marketing expense | 14.8b | 14.8b | 14.8b | ||

## R&D expense | 7.7b | 7.9b | 7.7b | 8.0b | 8.7b |

## General and administrative expense | 14.5b | 14.4b | |||

## Operating expense total | 22.5b | 22.7b | 22.4b | 22.5b | 23.0b |

## Depreciation and amortization | 3.7b | 4.1b | 4.8b | ||

## EBIT | 7.0b | 7.2b | 21.4b | ||

| 14% | 14% | 41% | ||

## Pre tax profit | 9.0b | 8.4b | 12.3b | 11.9b | 17.7b |

## Income tax expense | 2.0b | 1.1b | (9.0b) | 706.0m | 1.4b |

## Net Income | 7.0b | 7.2b | 21.3b | 11.2b | 16.3b |

USD | FY, 2015 | FY, 2016 | FY, 2017 | FY, 2018 | FY, 2019 |
---|---|---|---|---|---|

## Cash | 3.6b | 2.6b | 1.3b | 1.1b | 1.3b |

## Accounts Receivable | 8.0b | 8.7b | |||

## Prepaid Expenses | 2.5b | 2.6b | |||

## Inventories | 7.5b | 6.8b | 7.6b | 7.5b | 8.3b |

## Current Assets | 43.8b | 38.9b | 41.1b | 49.9b | 32.8b |

## PP&E | 13.8b | 13.3b | 13.9b | 13.4b | 14.0b |

## Goodwill | 48.2b | 54.4b | 56.0b | 53.4b | 58.7b |

## Total Assets | 167.4b | 171.6b | 171.8b | 159.0b | 167.5b |

## Accounts Payable | 3.6b | 4.5b | 4.7b | 4.7b | 4.2b |

## Dividends Payable | 1.9b | 1.9b | 2.0b | 2.0b | 2.1b |

## Short-term debt | 10.2b | 10.7b | 10.0b | 13.6b | 17.7b |

## Current Liabilities | 29.4b | 31.1b | 30.4b | 31.9b | 37.3b |

## Long-term debt | 28.7b | 31.4b | 33.5b | 32.9b | 36.0b |

## Total Debt | 38.9b | 42.1b | 43.5b | 32.9b | 53.6b |

## Total Liabilities | 102.4b | 111.8b | 100.1b | 95.7b | 104.0b |

## Common Stock | 459.0m | 461.0m | 464.0m | 467.0m | 468.0m |

## Preferred Stock | 26.0m | 24.0m | 21.0m | 19.0m | 17.0m |

## Additional Paid-in Capital | 81.0b | 82.7b | 84.3b | 86.3b | 87.4b |

## Retained Earnings | 72.0b | 71.8b | 85.3b | 89.6b | 97.7b |

## Total Equity | 65.0b | 59.8b | 71.7b | 63.8b | 63.4b |

## Debt to Equity Ratio | 0.6 x | 0.7 x | 0.6 x | 0.5 x | |

## Debt to Assets Ratio | 0.2 x | 0.2 x | 0.3 x | 0.2 x | |

## Financial Leverage | 2.6 x | 2.9 x | 2.4 x | 2.5 x | 2.6 x |

USD | Q1, 2016 | Q2, 2016 | Q3, 2016 | Q1, 2017 | Q2, 2017 | Q3, 2017 | Q1, 2018 | Q2, 2018 | Q3, 2018 | Q1, 2019 | Q2, 2019 | Q3, 2019 | Q1, 2020 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|

## Cash | 2.6b | 3.4b | 2.1b | 4.1b | 2.6b | 2.8b | 2.3b | 2.7b | 3.6b | 1.9b | 1.8b | 2.8b | 2.2b |

## Accounts Receivable | 9.6b | 9.8b | 9.4b | 9.9b | |||||||||

## Prepaid Expenses | 2.6b | 2.5b | 3.0b | ||||||||||

## Inventories | 7.6b | 7.6b | 7.5b | 7.4b | 7.6b | 7.9b | 8.1b | 8.1b | 8.2b | 8.0b | 8.2b | 8.2b | 8.4b |

## Current Assets | 41.3b | 43.8b | 38.5b | 35.9b | 36.4b | 40.3b | 34.8b | 37.3b | 41.6b | 45.3b | 47.1b | 33.5b | 34.7b |

## PP&E | 13.6b | 13.6b | 13.3b | 13.2b | 13.4b | 13.5b | 14.0b | 13.9b | 14.0b | 13.5b | 13.5b | 13.7b | 14.0b |

## Goodwill | 48.6b | 50.6b | 56.3b | 54.7b | 55.0b | 56.1b | 56.4b | 55.8b | 55.6b | 53.5b | 53.4b | 58.7b | 58.5b |

## Total Assets | 162.9b | 170.7b | 178.4b | 168.8b | 168.6b | 172.2b | 164.6b | 165.0b | 167.8b | 155.0b | 156.2b | 170.0b | 166.3b |

## Accounts Payable | 3.1b | 3.3b | 3.5b | 3.4b | 3.4b | 3.5b | 3.9b | 4.2b | 4.3b | 4.2b | 4.0b | 3.9b | 4.0b |

## Dividends Payable | 1.8b | 1.8b | 1.9b | 1.9b | 2.0b | 2.0b | 2.0b | 2.0b | |||||

## Short-term debt | 11.5b | 13.7b | 13.6b | 768.0m | 9.5b | 9.4b | 9.0b | 11.6b | 7.4b | 9.4b | 10.5b | 16.6b | 16.0b |

## Current Liabilities | 28.7b | 32.1b | 34.8b | 24.9b | 27.2b | 28.2b | 27.4b | 32.2b | 29.0b | 29.4b | 32.0b | 37.0b | 33.9b |

## Long-term debt | 27.8b | 30.5b | 30.4b | 36.3b | 34.2b | 34.5b | 31.8b | 28.9b | 33.7b | 35.7b | 36.2b | 36.0b | 36.3b |

## Total Debt | 39.4b | 44.2b | 44.1b | 37.1b | 43.7b | 44.0b | 40.8b | 40.5b | 41.0b | 35.7b | 46.7b | 52.7b | 52.3b |

## Total Liabilities | 99.6b | 107.6b | 114.8b | 110.0b | 109.9b | 111.0b | 94.1b | 94.9b | 96.2b | 96.3b | 96.3b | 105.1b | 101.0b |

## Common Stock | 460.0m | 461.0m | 461.0m | 463.0m | 463.0m | 463.0m | 465.0m | 465.0m | 466.0m | 468.0m | 468.0m | 468.0m | 470.0m |

## Preferred Stock | 26.0m | 25.0m | 25.0m | 23.0m | 23.0m | 22.0m | 21.0m | 20.0m | 20.0m | 19.0m | 18.0m | 18.0m | 17.0m |

## Additional Paid-in Capital | 81.4b | 82.1b | 82.5b | 83.1b | 83.4b | 83.8b | 84.6b | 84.9b | 85.8b | 86.6b | 87.0b | 87.1b | 87.7b |

## Retained Earnings | 75.0b | 73.4b | 72.8b | 74.8b | 74.1b | 75.0b | 90.0b | 89.9b | 92.0b | 93.4b | 94.4b | 100.1b | 101.0b |

## Total Equity | 63.3b | 63.1b | 63.6b | 58.7b | 58.7b | 61.1b | 70.5b | 70.1b | 71.7b | 59.2b | 59.9b | 65.4b | 65.3b |

## Debt to Equity Ratio | 0.6 x | 0.7 x | 0.7 x | 0.6 x | 0.7 x | 0.7 x | 0.6 x | 0.6 x | 0.6 x | 0.6 x | |||

## Debt to Assets Ratio | 0.2 x | 0.3 x | 0.2 x | 0.2 x | 0.3 x | 0.3 x | 0.2 x | 0.2 x | 0.2 x | 0.2 x | |||

## Financial Leverage | 2.6 x | 2.7 x | 2.8 x | 2.9 x | 2.9 x | 2.8 x | 2.3 x | 2.4 x | 2.3 x | 2.6 x | 2.6 x | 2.6 x | 2.5 x |

USD | FY, 2015 | FY, 2016 | FY, 2017 | FY, 2018 | FY, 2019 |
---|---|---|---|---|---|

## Net Income | 7.0b | 7.2b | 21.4b | 11.2b | 16.3b |

## Depreciation and Amortization | 5.2b | 5.8b | 6.3b | 6.4b | 6.0b |

## Accounts Receivable | 21.0m | (134.0m) | 259.0m | (644.0m) | (742.0m) |

## Inventories | (199.0m) | 365.0m | (357.0m) | (717.0m) | (1.0b) |

## Accounts Payable | 254.0m | 871.0m | 46.0m | 431.0m | (564.0m) |

## Cash From Operating Activities | 14.7b | 15.9b | 16.5b | 15.8b | 12.6b |

## Purchases of PP&E | (1.4b) | (1.8b) | (2.0b) | (2.0b) | (2.2b) |

## Cash From Investing Activities | (3.0b) | (7.8b) | (4.7b) | 4.5b | (3.9b) |

## Short-term Borrowings | (4.0b) | (5.1b) | (10.0b) | (4.4b) | (8.4b) |

## Long-term Borrowings | (3.0b) | (7.7b) | (6.2b) | (3.6b) | (6.8b) |

## Dividends Paid | (6.9b) | (7.3b) | (7.7b) | (8.1b) | (8.2b) |

## Cash From Financing Activities | (10.4b) | (8.9b) | (13.0b) | (20.4b) | (8.5b) |

## Net Change in Cash | 298.0m | (1.0b) | (1.3b) | (205.0m) | 125.0m |

## Interest Paid | 1.3b | 1.5b | 1.5b | 1.3b | 1.6b |

## Income Taxes Paid | 2.4b | 2.5b | 2.5b | 3.7b | 3.7b |

USD | Q1, 2016 | Q2, 2016 | Q3, 2016 | Q1, 2017 | Q2, 2017 | Q3, 2017 | Q1, 2018 | Q2, 2018 | Q3, 2018 | Q1, 2019 | Q2, 2019 | Q3, 2019 | Q1, 2020 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|

## Net Income | 3.0b | 5.1b | 6.5b | 3.1b | 6.2b | 9.1b | 3.6b | 7.4b | 11.6b | 3.9b | 8.9b | 16.6b | 3.4b |

## Depreciation and Amortization | 1.4b | 2.8b | 4.2b | 1.6b | 3.1b | 4.7b | 1.6b | 3.1b | 4.7b | ||||

## Cash From Operating Activities | 1.8b | 5.4b | 1.0b | 1.6b | 4.8b | 9.7b | 2.0b | 5.8b | 11.1b | 1.7b | 4.3b | 8.8b | 3.1b |

## Purchases of PP&E | (301.0m) | (702.0m) | (1.1b) | (358.0m) | (806.0m) | (1.3b) | (386.0m) | (810.0m) | (1.4b) | (460.0m) | (939.0m) | (1.5b) | (463.0m) |

## Cash From Investing Activities | 4.4b | (323.0m) | (4.7b) | 4.8b | 3.0b | 19.0m | 9.7b | 8.2b | 5.3b | 7.6b | 5.6b | (1.1b) | (71.0m) |

## Short-term Borrowings | (1.3b) | (2.3b) | (3.3b) | (2.5b) | (5.1b) | (7.7b) | (83.0m) | (2.9b) | (4.2b) | (3.8b) | (2.4b) | (4.1b) | (7.6b) |

## Long-term Borrowings | (1.5b) | (4.3b) | (4.3b) | (1.3b) | (4.5b) | (4.5b) | (355.0m) | (3.1b) | (3.1b) | (3.0b) | (5.4b) | (5.8b) | (2.2b) |

## Dividends Paid | (1.9b) | (3.7b) | (5.5b) | (1.9b) | (3.9b) | (5.7b) | (2.0b) | (4.0b) | (6.0b) | (68.0m) | (4.1b) | (6.1b) | (71.0m) |

## Cash From Financing Activities | (7.1b) | (5.3b) | (6.9b) | (4.9b) | (7.9b) | (9.6b) | (10.7b) | (12.6b) | (14.0b) | (8.5b) | (9.3b) | (6.0b) | (2.2b) |

## Net Change in Cash | (1.1b) | (230.0m) | (1.5b) | 1.5b | (5.0m) | 193.0m | 985.0m | 1.4b | 2.2b | 792.0m | 612.0m | 1.6b | 846.0m |

## Interest Paid | 409.0m | 903.0m | 1.2b | 216.0m | 881.0m | 1.1b | 259.0m | 724.0m | 968.0m | 385.0m | 809.0m | 1.2b | 472.0m |

## Income Taxes Paid | 518.0m | 1.1b | 1.4b | 195.0m | 1.1b | 1.4b | 257.0m | 1.2b | 1.7b | 235.0m | 2.1b | 2.6b | 239.0m |

USD | Y, 2020 |
---|---|

## EV/EBIT | 76 x |

## EV/CFO | 82.5 x |

## Financial Leverage | 2.5 x |

Pfizer's Properties was reported to be 501 in FY, 2017.

- Source: Company Filings

FY, 2018 | |
---|---|

## Water Withdrawn | 16.30 m cubic meters |

## Nonhazardous Waste (Recycled) | 23 k metric tons |

## Nonhazardous Waste (Disposed) | 26.70 k metric tons |

## Hazardous Waste (Recycled) | 17.60 k metric tons |

## Hazardous Waste (Disposed) | 70.10 k metric tons |

## Greenhouse Gas Emissions (Scope 2) | 920 k metric tons of carbon dioxide equivalent |

## Greenhouse Gas Emissions (Scope 1) | 760 k metric tons of carbon dioxide equivalent |

## Energy Used | 20.30 k TJ |